Regional healthcare company Gujarat Kidney and Super Speciality has launched its Initial Public Offering (IPO) for public subscription today, December 22, 2025. Prior to the IPO opening, the company has raised ₹100 crore from anchor investors on December 19, 2025.
Issue Type: The Gujarat Kidney and Super Speciality IPO is a book-building issue of ₹250.80 crore, consisting entirely of a fresh issue of 2.20 crore shares.
Lot Size: 128 shares
Price Band: ₹108-₹114 per share
Minimum Investment: ₹14,592 (for retail investors)
IPO Closing Date: December 24, 2025
Allotment Date: The basis of allotment will be finalised by December 26, 2025.
Listing Date: The tentative listing date on BSE and NSE is December 30, 2025.
Book Running Lead Manager: Nirbhay Capital Services Private Limited
Registrar: MUFG Intime India Private Limited
[22-December-2025 11:06:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.00 |
|
Non-Institutional Investors |
0.42 |
|
Retail Individual Investors (RIIs) |
1.69 |
|
Total |
0.39 |
The net proceeds from the fresh issue will be used towards the following objectives:
As per media reports, the Grey Market Premium (GMP) of Gujarat Kidney and Super Speciality is reported at ₹7 over the IPO price.
Gujarat Kidney and Super Speciality Hospital is a super speciality healthcare facility located in Vadodara, Gujarat. The hospital provides a comprehensive range of medical and surgical services, with core expertise in nephrology, urology, renal transplantation, and other high-end specialities. In addition, it offers treatment across general medicine and surgery, cardiology, neurology, oncology, gastroenterology, orthopaedics, and other allied disciplines.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here